Historical record - last NADAC effective date: 2/17/2016
This NDC is on FDA's drug shortage list (posted Feb 22, 2012)
Product Information
LIDOCAINE HCL 1% AMPUL is a generic product labeled by Hospira Inc., priced at $0.2502 per ML under NDC 00409471302. Its NADAC has been published 166 times since Dec 18, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Hospira Inc.NDC
00409471302
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL
Effective Date
2/17/2016
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA080408FDA Approved
Before 1982
TE Code
AP
On Market Since
7/8/2005
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 1% AMPUL has been published 166 times since Dec 18, 2013, and over the history we have for it it has risen 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2502 per ML |
|---|---|
| All-time high | $0.2502 (Feb 15, 2017) |
| All-time low | $0.2094 (Jul 23, 2014) |
| Median price | $0.2260 |
| Average price | $0.2299 |
| Largest weekly change | +10.7% (Feb 17, 2016) |
| Weeks tracked | 166 |
| Tracking since | Dec 18, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+11.7%
Last surveyed Feb 15, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 78% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LIDOCAINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 1% AMPUL?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 1% AMPUL, manufactured by Hospira Inc., is $0.2502 per ML (NDC 00409471302), effective Feb 15, 2017.
How has the price of LIDOCAINE HCL 1% AMPUL changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 1% AMPUL has risen 11.7%. It has been tracked across 166 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 1% AMPUL?
Since Dec 18, 2013, the NADAC for LIDOCAINE HCL 1% AMPUL has ranged from a low of $0.2094 (Jul 23, 2014) to a high of $0.2502 (Feb 15, 2017), with a median of $0.2260 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 1% AMPUL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 1% VIAL, is $0.0542 per ML — about 78% below LIDOCAINE HCL 1% AMPUL.
Who manufactures LIDOCAINE HCL 1% AMPUL?
LIDOCAINE HCL 1% AMPUL (NDC 00409471302) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is LIDOCAINE HCL 1% AMPUL in shortage?
Yes — NDC 00409471302 is currently listed in FDA's drug shortage database (posted Feb 22, 2012).